Dobutamine pretreatment improves survival, liver function, and hepatic microcirculation after polymicrobial sepsis in rat

Shock

Volumn 40, Issue 2, 2013, Pages 129-135

  Fink, Tobias ^a   Heymann, Paul ^a   Taha Melitz, Stefanie ^a   Taha, Anas ^a   Wolf, Beate ^a   Rensing, Hauke ^b   Volk, Thomas ^a   Mathes, Alexander M ^c  

^a SAARLAND UNIVERSITY   (Germany)

^b Leopoldina Hospital   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

1 adrenoceptor; Esmolol; Hepatic perfusion index; Intravital microscopy; PDR ICG

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; DOBUTAMINE; ESMOLOL; GLUTAMATE DEHYDROGENASE; INDOCYANINE GREEN; PROPIDIUM IODIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; EXPERIMENTAL LIGATION; GENERAL ANESTHESIA; INCISION; LIVER CELL DAMAGE; LIVER CIRCULATION; LIVER FUNCTION; LIVER PERFUSION; LIVER PROTECTION; MALE; MICROCIRCULATION; NONHUMAN; PLASMA CLEARANCE; RAT; SEPSIS; SHAM PROCEDURE; STAINING; SURVIVAL; SURVIVAL TIME;

ANIMALS; DOBUTAMINE; HEMODYNAMICS; LIVER; MALE; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; RATS; SEPSIS;

EID: 84880844063     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31829c361d     Document Type: Article

References (43)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
2. Linde-Zwirble WT, Angus DC: Severe sepsis epidemiology: Sampling, selection and society. Crit Care 8:222-226, 2004.
3. Fry DE, Pearlstein L, Fulton RL, Polk HC Jr: Multiple system organ failure. The role of uncontrolled infection. Arch Surg 115:136-140, 1980.
4. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 271:226-233, 1994.
5. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al.: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 36:296-327, 2008.
6. Secchi A, Wellmann R, Martin E, Schmidt H: Dobutamine maintains intestinal villus blood flow during normotensive endotoxemia: An intravital microscopic study in the rat. J Crit Care 12:137-141, 1997.
7. Secchi A, Ortanderl JM, Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H: Effects of dobutamine and dopexamine on hepatic micro- and macrocirculation during experimental endotoxemia: An intravital microscopic study in rat. Crit Care Med 29:597-600, 2001.
8. Christ F, Gartside IB, Kox WJ, Gamble J: The assessment of the microcirculatory effects of dobutamine using mercury in silastic strain gauge plethysmography in man. Postgrad Med J 67:S42YS50, 1991.
9. Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, Samii K: Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 27: 893-900, 1999.
10. Taurà P, Fuster J, Mercadal J, Martinez-Palli G, Fondevila C, Blasi A, Balust J, Garcia-Valdecasas JC: The use of beta-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection. J Hepatol 52:340-347, 2010.
11. Raddatz A, Kubulus D, Winning J, Bauer I, Pradarutti S, Wolf B, Kreuer S, Rensing H: Dobutamine improves liver function after hemorrhagic shock through induction of heme oxygenase-1. Am J Respir Crit Care Med 174: 198-207, 2006.
12. Scheiermann P, Hoegl S, Revermann M, Ahluwalia D, Zander J, Boost KA, Nguyen T, Zwissler B, Muhl H, Hofstetter C: Cecal ligation and incision: An acute onset model of severe sepsis in rats. J Surg Res 151:132-137, 2009.
13. Mathes AM, Kubulus D, Weiler J, Bentley A, Waibel L, Wolf B, Bauer I, Rensing H: Melatonin receptors mediate improvements of liver function but not of hepatic perfusion and integrity after hemorrhagic shock in rats. Crit Care Med 36:24-29, 2008.
14. Zimmerhackl B, Parekh N, Brinkhus H, Steinhausen M: The use of fluorescent labeled erythrocytes for intravital investigation of flow and local hematocrit in glomerular capillaries in the rat. Int J Microcirc Clin Exp 2:119-129, 1983.
15. Bauer I, Bauer M, Pannen BH, Leinwand MJ, Zhang JX, Clemens MG: Chronic ethanol consumption exacerbates liver injury following hemorrhagic shock: Role of sinusoidal perfusion failure. Shock 4:324-331, 1995.
16. Vallet B, Dupuis B, Chopin C: Dobutamine: Mechanisms of action and use in acute cardiovascular pathology. Ann Cardiol Angeiol 40:397-402, 1991.
17. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S: The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 21:43-57, 1961.
18. Wheeler HO, Carnaston WI, Meltzer JI: Hepatic uptake and biliary excretion of indocyanine green in the dog. Proc Soc Exp Biol Med 99:11-14, 1958.
19. Memiz D, Inal MT, Sut N: The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shock. J Crit Care 27:318e1-318e6, 2012.
20. Joly LM, Monchi M, Cariou A, Chiche JD, Bellenfant F, Brunet F, Dhainaut JF: Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock. Am J Respir Crit Care Med 160:1983-1986, 1999.
21. De Backer D, Creteur J, Noordally O, Smail N, Gulbis B, Vincent JL: Does hepato-splanchnic VO2/DO2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 157:1219-1225, 1998.
22. Wang D, Jose P, Wilcox CS: Beta(1) Receptors protect the renal afferent arteriole of angiotensin-infused rabbits from norepinephrine-induced oxidative stress. J Am Soc Nephrol 17:3347-3354, 2006.
23. Miura T, Muraoka S, Ogiso T: Antioxidant activity of adrenergic agents derived from catechol. Biochem Pharmacol 55:2001-2006, 1998.
24. Rosario AL, Park M, Brunialti MK, Mendes M, Rapozo M, Fernandes D, Salomao R, Laurindo FR, Schettino GP, Azevedo LC: SvO(2)-guided resuscitation for experimental septic shock: Effects of fluid infusion and dobutamine on hemodynamics, inflammatory response, and cardiovascular oxidative stress. Shock 36:604-612, 2011.
25. Singer G, Urakami H, Specian RD, Stokes KY, Granger DN: Platelet recruitment in the murine hepatic microvasculature during experimental sepsis: Role of neutrophils. Microcirculation 13:89-97, 2006.
26. Madorin WS, Martin CM, Sibbald WJ: Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis. Crit Care Med 27: 394-400, 1999.
27. Schmidt H, Secchi A, Wellmann R, Bach A, Bhrer H, Martin E: Dopexamine maintains intestinal villus blood flow during endotoxemia in rats. Crit Care Med 24:1233-1237, 1996.
28. Lobo SM, Soriano FG, Barbeiro DF, De Backer D, Sun Q, Tu Z, Dimopoulos G, Preiser JC, Vray B, Vercruysse V, et al.: Effects of dobutamine on gut mucosal nitric oxide production during endotoxic shock in rabbits. Med Sci Monit 15:37-42, 2009.
29. De Backer D, Zhang H, Manikis P, Vincent JL: Regional effects of dobutamine in endotoxic shock. J Surg Res 65:93-100, 1996.
30. De Backer D, Zhang H, Cherkhaoui S, Borgers M, Vincent JL: Effects of dobutamine on hepato-splanchnic hemodynamics in an experimental model of hyperdynamic endotoxic shock. Shock 15:208-214, 2001.
31. Reinelt H, Radermacher P, Fischer G, Geisser W, Wachter U, Wiedeck H, Georgieff M, Vogt J: Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 86:818-824, 1997.
32. Van Lambalgen AA, van Kraats AA, Mulder MF, Teerlink T, van den Bos GC: High-energy phosphates in heart, liver, kidney, and skeletal muscle of endotoxemic rats. Am J Physiol 266:1581-1587, 1994.
33. Rensing H, Bauer I, Kubulus D, Wolf B, Winning J, Ziegeler S, Bauer M: Heme oxygenase-1 gene expression in pericentral hepatocytes through beta1-adrenoceptor stimulation. Shock 21:376-387, 2004.
34. Kubulus D, Rensing H, Paxian M, Thierbach JT, Meisel T, Redl H, Bauer M, Bauer I: Influence of heme-based solutions on stress protein expression and organ failure after hemorrhagic shock. Crit Care Med 33:629-637, 2005.
35. O'Brien PJ, Slaughter MR, Polley SR, Kramer K: Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats. Lab Anim 36:313-321, 2002.
36. Ackland GL, Yao ST, Rudiger A, Dyson A, Stidwill R, Poputnikov D, Singer M, Gourine AV: Cardioprotection, attenuated systemic inflammation, and survival benefit of beta-1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med 38:388-394, 2010.
37. Aboab J, Sebille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, Annane D: Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med 37:1344-1351, 2011.
38. Hagiwara S, Iwasaka H, Maeda H, Noguchi T: Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock 31:515-520, 2009.
39. Schmitz D, Wilsenack K, Lendemanns S, Schedlowski M, Oberbeck R: Beta-Adrenergic blockade during systemic inflammation: Impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation 72: 286-294, 2007.
40. Oberbeck R, Schmitz D, Wilsenack K, Schüler M, Pehle B, Schedlowski M, Exton MS: Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation 11:214-223, 2004.
41. POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, et al.: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet 371:1839-1847, 2008.
42. Freestone PP, Williams PH, Haigh RD, Maggs AF, Neal CP, Lyte M: Growth stimulation of intestinal commensal Escherichia coli by catecholamines: A possible contributory factor in trauma-induced sepsis. Shock 18:465-470, 2002.
43. Bergmann M, Sautner T: Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr 114:752-761, 2002.